BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 16191502)

  • 21. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
    Bode MK; Rissanen T; Apaja-Sarkkinen M
    Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multinucleated stromal giant cells in mammary fibroepithelial neoplasms. A study of 11 patients.
    Powell CM; Cranor ML; Rosen PP
    Arch Pathol Lab Med; 1994 Sep; 118(9):912-6. PubMed ID: 8080361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
    Maritz RM; Michelow PM
    Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Tamsen A
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
    Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
    Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
    Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
    Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paediatric fibroepithelial lesions revisited: pathological insights.
    Tay TK; Chang KT; Thike AA; Tan PH
    J Clin Pathol; 2015 Aug; 68(8):633-41. PubMed ID: 25998513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
    Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
    Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential cytologic features of fibroepithelial lesions of the breast.
    Deen SA; McKee GT; Kissin MW
    Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of pathologic prognostic factors in breast core needle biopsies.
    Sharifi S; Peterson MK; Baum JK; Raza S; Schnitt SJ
    Mod Pathol; 1999 Oct; 12(10):941-5. PubMed ID: 10530557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
    Aiyer HM; Jain M; Thomas S; Logani KB
    Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy.
    Wiratkapun C; Piyapan P; Lertsithichai P; Larbcharoensub N
    Diagn Interv Radiol; 2014; 20(1):27-33. PubMed ID: 24356293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cellular (juvenile) fibroadenoma of the breast. A clinico-pathologic and immunohistochemical study of 7 cases].
    Remadi S; Ismail A; Karpuz V; Finci V; Zacharie S; Vassilakos P
    Ann Pathol; 1994; 14(6):392-7. PubMed ID: 7857414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
    Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
    Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Needle core biopsy in the diagnosis of phyllodes neoplasm.
    Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD
    Surgery; 2006 Nov; 140(5):779-84. PubMed ID: 17084721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of histological features in needle core biopsy of breast useful in preoperative distinction between fibroadenoma and phyllodes tumour.
    Morgan JM; Douglas-Jones AG; Gupta SK
    Histopathology; 2010 Mar; 56(4):489-500. PubMed ID: 20459556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
    Li JJX; Tse GM
    Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytologic evaluation of phyllodes tumors as compared to fibroadenomas of the breast.
    Shimizu K; Masawa N; Yamada T; Okamoto K; Kanda K
    Acta Cytol; 1994; 38(6):891-7. PubMed ID: 7992575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay.
    Kuijper A; Buerger H; Simon R; Schaefer KL; Croonen A; Boecker W; van der Wall E; van Diest PJ
    J Pathol; 2002 Aug; 197(5):575-81. PubMed ID: 12210075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.